1. Home
  2. OPK vs REX Comparison

OPK vs REX Comparison

Compare OPK & REX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPK
  • REX
  • Stock Information
  • Founded
  • OPK 2007
  • REX 1980
  • Country
  • OPK United States
  • REX United States
  • Employees
  • OPK N/A
  • REX 122
  • Industry
  • OPK Biotechnology: Pharmaceutical Preparations
  • REX Major Chemicals
  • Sector
  • OPK Health Care
  • REX Industrials
  • Exchange
  • OPK Nasdaq
  • REX Nasdaq
  • Market Cap
  • OPK 1.1B
  • REX 861.0M
  • IPO Year
  • OPK 1995
  • REX N/A
  • Fundamental
  • Price
  • OPK $1.19
  • REX $50.95
  • Analyst Decision
  • OPK Buy
  • REX Strong Buy
  • Analyst Count
  • OPK 4
  • REX 1
  • Target Price
  • OPK $2.75
  • REX $50.00
  • AVG Volume (30 Days)
  • OPK 2.8M
  • REX 85.7K
  • Earning Date
  • OPK 07-31-2025
  • REX 08-26-2025
  • Dividend Yield
  • OPK N/A
  • REX N/A
  • EPS Growth
  • OPK N/A
  • REX N/A
  • EPS
  • OPK N/A
  • REX 3.24
  • Revenue
  • OPK $664,029,000.00
  • REX $639,600,000.00
  • Revenue This Year
  • OPK N/A
  • REX $3.27
  • Revenue Next Year
  • OPK $6.98
  • REX $17.11
  • P/E Ratio
  • OPK N/A
  • REX $16.15
  • Revenue Growth
  • OPK N/A
  • REX N/A
  • 52 Week Low
  • OPK $1.11
  • REX $33.45
  • 52 Week High
  • OPK $2.04
  • REX $55.36
  • Technical
  • Relative Strength Index (RSI)
  • OPK 29.73
  • REX 43.88
  • Support Level
  • OPK $1.34
  • REX $53.27
  • Resistance Level
  • OPK $1.38
  • REX $54.80
  • Average True Range (ATR)
  • OPK 0.06
  • REX 1.29
  • MACD
  • OPK -0.02
  • REX -0.62
  • Stochastic Oscillator
  • OPK 23.53
  • REX 21.39

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

About REX REX American Resources Corporation

REX American Resources Corp operates as a holding company, which engages in investment in alternative energy and ethanol production entities. Its operating segments include Ethanol and By-Products. Its products include dried distillers grains, modified distillers grains, and non-food grade corn oil.

Share on Social Networks: